Mechanism of metastasis suppression by luteolin in breast cancer
Matthew T Cook Department of Biology, Washburn University, Topeka, KS, USA Abstract: Metastatic breast cancer is typically an extremely aggressive cancer with poor prognosis. Metastasis requires the orchestration of homeostatic factors and cellular programs, many of which are potential therapeutic t...
Guardado en:
Autor principal: | Cook MT |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b1616cfbccc14ac4993b8c385421598c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells
por: Cook MT, et al.
Publicado: (2016) -
CCR9 initiates epithelial–mesenchymal transition by activating Wnt/β-catenin pathways to promote osteosarcoma metastasis
por: Haoran Kong, et al.
Publicado: (2021) -
TGFβ Signaling in Myeloid Cells Promotes Lung and Liver Metastasis Through Different Mechanisms
por: Cristina Stefanescu, et al.
Publicado: (2021) -
WNT/β-Catenin Pathway in Soft Tissue Sarcomas: New Therapeutic Opportunities?
por: Esther Martinez-Font, et al.
Publicado: (2021) -
Perifosine, a Bioavailable Alkylphospholipid Akt Inhibitor, Exhibits Antitumor Activity in Murine Models of Cancer Brain Metastasis Through Favorable Tumor Exposure
por: Keisuke Taniguchi, et al.
Publicado: (2021)